These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Immune evasion as a pathogenic mechanism of varicella zoster virus. Abendroth A; Arvin AM Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797 [TBL] [Abstract][Full Text] [Related]
25. Variations in herpes zoster manifestation. Wollina U Indian J Med Res; 2017 Mar; 145(3):294-298. PubMed ID: 28749391 [TBL] [Abstract][Full Text] [Related]
26. Humoral and cellular immunity to varicella-zoster virus: an overview. Arvin AM J Infect Dis; 2008 Mar; 197 Suppl 2():S58-60. PubMed ID: 18419410 [No Abstract] [Full Text] [Related]
27. Herpes zoster: epidemiology, clinical features, and management. Reuler JB; Chang MK South Med J; 1984 Sep; 77(9):1149-56. PubMed ID: 6207596 [TBL] [Abstract][Full Text] [Related]
28. [Item no 84: herpes virus infections in immunocompetent children and adults: varicella and zona]. Ann Dermatol Venereol; 2005 Oct; 132(10 Suppl):7S28-7S34. PubMed ID: 16419517 [No Abstract] [Full Text] [Related]
30. Varicella and herpes zoster appearing over sites of tinea corporis, hitherto unreported examples of immunocompromised districts: a case series. Verma SB; Gupta S; Yadav A; Ruocco E Int J Dermatol; 2020 Jun; 59(6):758-759. PubMed ID: 32072634 [No Abstract] [Full Text] [Related]
31. [Herpes zoster]. Yoshida M Nihon Rinsho; 2006 Mar; 64 Suppl 3():260-3. PubMed ID: 16615479 [No Abstract] [Full Text] [Related]
32. [Reactivation of herpes zoster infection by varicella-zoster virus]. Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396 [TBL] [Abstract][Full Text] [Related]
33. [Autoimmune hepatitis type 1 triggered by cytomegalovirus infection. One rare case report]. Mouelhi L; Debbeche R; Salem M; Bouzaidi S; Mekki H; Houissa F; Said Y; Moussa A; Rejeb MB; Trabelsi S; Najjar T Tunis Med; 2010 Sep; 88(9):674-7. PubMed ID: 20812184 [TBL] [Abstract][Full Text] [Related]
34. Zoster sine herpete causing encephalomyelitis. Mancardi GL; Melioli G; Traverso F; Tabaton M; Farinelli M; Terragna A Ital J Neurol Sci; 1987 Feb; 8(1):67-70. PubMed ID: 3032844 [TBL] [Abstract][Full Text] [Related]
35. Facial herpes zoster complicated by varicella zoster virus (VZV) encephalitis: The diagnostic significance of atypical lymphocytes in cerebrospinal fluid (CSF). Cunha BA; Strollo S; Durie N; Ibrahim MS Heart Lung; 2011; 40(2):164-7. PubMed ID: 21144586 [TBL] [Abstract][Full Text] [Related]
36. Varicella-zoster virus: aspects of pathogenesis and host response to natural infection and varicella vaccine. Arvin AM; Moffat JF; Redman R Adv Virus Res; 1996; 46():263-309. PubMed ID: 8824702 [TBL] [Abstract][Full Text] [Related]
37. Approaches to the treatment of varicella-zoster virus infections. Whitley RJ Contrib Microbiol; 1999; 3():158-72. PubMed ID: 10599529 [No Abstract] [Full Text] [Related]
38. Varicella zoster virus reactivation and the increased risk of cerebrovascular accidents: the unexpected role dermatologists can play. Gil F; Rato M; Parente J; Teixeira N; Dias M; Duarte M Dermatol Online J; 2018 Aug; 24(8):. PubMed ID: 30677857 [TBL] [Abstract][Full Text] [Related]
39. Atypical vasculopathic varicella-zoster infection mimicking cutaneous small-vessel vasculitis. Álvarez-Salafranca M; Garcés-Horna V; García-García M; Ara-Martín M Int J Dermatol; 2020 Jun; 59(6):e214-e216. PubMed ID: 32052407 [No Abstract] [Full Text] [Related]
40. [Detection of serum IgA antibodies to varicella zoster virus (VZV)--differential etiology of peripheral facial paralysis. A case report]. May G; May W Laryngorhinootologie; 1995 Sep; 74(9):553-4. PubMed ID: 7495437 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]